| Ident. | Authors (with country if any) | Title |
|---|
| 000412 (2017) |
Meletios A. Dimopoulos ; Hartmut Goldschmidt ; Ruben Niesvizky ; Douglas Joshua ; Wee-Joo Chng ; Albert Oriol ; Robert Z. Orlowski ; Heinz Ludwig ; Thierry Facon ; Roman Hajek ; Katja Weisel ; Vania Hungria ; Leonard Minuk ; Shibao Feng ; Anita Zahlten-Kumeli ; Amy S. Kimball ; Philippe Moreau | Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial. |
| 000665 (2017) |
Christophe Hézode ; Massimo Colombo ; Marc Bourlière ; Ulrich Spengler ; Ziv Ben-Ari ; Simone I. Strasser ; William M. Lee ; Leslie Morgan ; Jingjun Qiu ; Peggy Hwang ; Michael Robertson ; Bach-Yen Nguyen ; Eliav Barr ; Janice Wahl ; Barbara Haber ; Robert Chase ; Rohit Talwani ; Vito Di Marco | Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study. |
| 000743 (2017) |
Shaji Kumar ; Philippe Moreau ; Parameswaran Hari ; Maria-Victoria Mateos ; Heinz Ludwig ; Chaim Shustik ; Tamas Masszi ; Andrew Spencer ; Roman Hájek ; Kenneth Romeril ; Irit Avivi ; Anna M. Liberati ; Monique C. Minnema ; Hermann Einsele ; Sagar Lonial ; Deborah Berg ; Jianchang Lin ; Neeraj Gupta ; Dixie-Lee Esseltine ; Paul G. Richardson | Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. |
| 001093 (2017) |
Abdulaziz S. Alobaid ; Steven C. Wallis ; Paul Jarrett ; Therese Starr ; Janine Stuart ; Melissa Lassig-Smith ; Jenny Lisette Ord Ez Mejia ; Michael S. Roberts ; Claire Roger ; Andrew A. Udy ; Jeffrey Lipman ; Jason A. Roberts | Population Pharmacokinetics of Piperacillin in Nonobese, Obese, and Morbidly Obese Critically Ill Patients. |
| 001346 (2017) |
Hartmut Döhner ; Elihu Estey ; David Grimwade ; Sergio Amadori ; Frederick R. Appelbaum ; Thomas Büchner ; Hervé Dombret ; Benjamin L. Ebert ; Pierre Fenaux ; Richard A. Larson ; Ross L. Levine ; Francesco Lo-Coco ; Tomoki Naoe ; Dietger Niederwieser ; Gert J. Ossenkoppele ; Miguel Sanz ; Jorge Sierra ; Martin S. Tallman ; Hwei-Fang Tien ; Andrew H. Wei ; Bob Löwenberg ; Clara D. Bloomfield | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. |
| 001430 (2016) |
Adil I. Daud ; Jedd D. Wolchok ; Caroline Robert ; Wen-Jen Hwu ; Jeffrey S. Weber ; Antoni Ribas ; F Stephen Hodi ; Anthony M. Joshua ; Richard Kefford ; Peter Hersey ; Richard Joseph ; Tara C. Gangadhar ; Roxana Dronca ; Amita Patnaik ; Hassane Zarour ; Charlotte Roach ; Grant Toland ; Jared K. Lunceford ; Xiaoyun Nicole Li ; Kenneth Emancipator ; Marisa Dolled-Filhart ; S Peter Kang ; Scot Ebbinghaus ; Omid Hamid | Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma. |
| 001656 (2016) |
Gabriel N. Hortobagyi ; Salomon M. Stemmer ; Howard A. Burris ; Yoon-Sim Yap ; Gabe S. Sonke ; Shani Paluch-Shimon ; Mario Campone ; Kimberly L. Blackwell ; Fabrice André ; Eric P. Winer ; Wolfgang Janni ; Sunil Verma ; Pierfranco Conte ; Carlos L. Arteaga ; David A. Cameron ; Katarina Petrakova ; Lowell L. Hart ; Cristian Villanueva ; Arlene Chan ; Erik Jakobsen ; Arnd Nusch ; Olga Burdaeva ; Eva-Maria Grischke ; Emilio Alba ; Erik Wist ; Norbert Marschner ; Anne M. Favret ; Denise Yardley ; Thomas Bachelot ; Ling-Ming Tseng ; Sibel Blau ; Fengjuan Xuan ; Farida Souami ; Michelle Miller ; Caroline Germa ; Samit Hirawat ; Joyce O'Shaughnessy | Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. |
| 001745 (2016) |
Abdulaziz S. Alobaid ; Steven C. Wallis ; Paul Jarrett ; Therese Starr ; Janine Stuart ; Melissa Lassig-Smith ; Jenny Lisette Ord Ez Mejia ; Michael S. Roberts ; Mahipal G. Sinnollareddy ; Claire Roger ; Jeffrey Lipman ; Jason A. Roberts | Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients. |
| 001A37 (2016) |
A. Kumar ; T. Awata ; S C Bain ; A. Ceriello ; G R Fulcher ; A G Unnikrishnan ; R. Arechavaleta ; G. Gonzalez-Gálvez ; T. Hirose ; P D Home ; K. Kaku ; L. Litwak ; S. Madsbad ; M. Pinget ; R. Mehta ; A. Mithal ; M. Tambascia ; J. Tibaldi ; J S Christiansen | Clinical use of the co-formulation of insulin degludec and insulin aspart. |
| 001B32 (2016) |
Andrea Cipriani ; Xinyu Zhou ; Cinzia Del Giovane ; Sarah E. Hetrick ; Bin Qin ; Craig Whittington ; David Coghill ; Yuqing Zhang ; Philip Hazell ; Stefan Leucht ; Pim Cuijpers ; Juncai Pu ; David Cohen ; Arun V. Ravindran ; Yiyun Liu ; Kurt D. Michael ; Lining Yang ; Lanxiang Liu ; Peng Xie | Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. |
| 001C21 (2016) |
Jennifer Yu ; Usman Baber ; Ioannis Mastoris ; George Dangas ; Samantha Sartori ; Philippe Gabriel Steg ; David J. Cohen ; Gennaro Giustino ; Jaya Chandrasekhar ; Cono Ariti ; Bernhard Witzenbichler ; Timothy D. Henry ; Annapoorna S. Kini ; Mitchell W. Krucoff ; C Michael Gibson ; Alaide Chieffo ; David J. Moliterno ; Antonio Colombo ; Stuart Pocock ; Roxana Mehran | Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. |
| 001E01 (2016) |
Patrice Carde ; Matthias Karrasch ; Catherine Fortpied ; Pauline Brice ; Hussein Khaled ; Olivier Casasnovas ; Denis Caillot ; Isabelle Gaillard ; Serge Bologna ; Christophe Ferme ; Pieternella Johanna Lugtenburg ; Frank Morschhauser ; Igor Aurer ; Bertrand Coiffier ; Ralph Meyer ; Matthew Seftel ; Max Wolf ; Bengt Glimelius ; Anna Sureda ; Nicolas Mounier | Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial. |
| 001F75 (2016) |
Antoni Ribas ; Omid Hamid ; Adil Daud ; F Stephen Hodi ; Jedd D. Wolchok ; Richard Kefford ; Anthony M. Joshua ; Amita Patnaik ; Wen-Jen Hwu ; Jeffrey S. Weber ; Tara C. Gangadhar ; Peter Hersey ; Roxana Dronca ; Richard W. Joseph ; Hassane Zarour ; Bartosz Chmielowski ; Donald P. Lawrence ; Alain Algazi ; Naiyer A. Rizvi ; Brianna Hoffner ; Christine Mateus ; Kevin Gergich ; Jill A. Lindia ; Maxine Giannotti ; Xiaoyun Nicole Li ; Scot Ebbinghaus ; S Peter Kang ; Caroline Robert | Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma. |
| 001F87 (2016) |
Michelle L. O'Donoghue ; Ruchira Glaser ; Matthew A. Cavender ; Philip E. Aylward ; Marc P. Bonaca ; Andrzej Budaj ; Richard Y. Davies ; Mikael Dellborg ; Keith A A. Fox ; Jorge Antonio T. Gutierrez ; Christian Hamm ; Robert G. Kiss ; František Kovar ; Julia F. Kuder ; Kyung Ah Im ; John J. Lepore ; Jose L. Lopez-Sendon ; Ton Oude Ophuis ; Alexandr Parkhomenko ; Jennifer B. Shannon ; Jindrich Spinar ; Jean-Francois Tanguay ; Mikhail Ruda ; P Gabriel Steg ; Pierre Theroux ; Stephen D. Wiviott ; Ian Laws ; Marc S. Sabatine ; David A. Morrow | Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction: A Randomized Clinical Trial. |
| 001F92 (2016) |
Steven A. Limentani ; Mario Campone ; Thierry Dorval ; Giuseppe Curigliano ; Richard De Boer ; Charles Vogel ; Shane White ; Thomas Bachelot ; Jean-Luc Canon ; Mary Disis ; Ahmad Awada ; Martine Berlière ; Frédéric Amant ; Ellis Levine ; Wivine Burny ; Andrea Callegaro ; Pedro Miguel De Sousa Alves ; Jamila Louahed ; Vincent Brichard ; Frédéric F. Lehmann | A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors. |
| 002068 (2016) |
Maciej Murawski ; Víola B. Weeda ; Rudolf Maibach ; Bruce Morland ; Derek J. Roebuck ; Arthur Zimmerman ; Michela Casanova ; Giorgio Perilongo ; Veronique Laithier ; Rejin Kebudi ; Marcelo J. Scopinaro ; Albert Shun ; Benedicte Brichard ; Beatriz De Camargo ; Margaret Childs ; Daniel C. Aronson ; Piotr Czauderna | Hepatocellular Carcinoma in Children: Does Modified Platinum- and Doxorubicin-Based Chemotherapy Increase Tumor Resectability and Change Outcome? Lessons Learned From the SIOPEL 2 and 3 Studies. |
| 002070 (2016) |
R K Ramanathan ; D. Goldstein ; R L Korn ; F. Arena ; M. Moore ; S. Siena ; L. Teixeira ; J. Tabernero ; J-L Van Laethem ; H. Liu ; D. Mcgovern ; B. Lu ; D D Von Hoff | Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas. |
| 002085 (2016) |
Marc P. Bonaca ; Deepak L. Bhatt ; P Gabriel Steg ; Robert F. Storey ; Marc Cohen ; Kyungah Im ; Ton Oude Ophuis ; Andrej Budaj ; Shinya Goto ; José L Pez-Send N ; Rafael Diaz ; Anthony Dalby ; Frans Van De Werf ; Diego Ardissino ; Gilles Montalescot ; Philip Aylward ; Giulia Magnani ; Eva C. Jensen ; Peter Held ; Eugene Braunwald ; Marc S. Sabatine | Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. |
| 002108 (2016) |
Francine Foss ; Steven Horwitz ; Barbara Pro ; H Miles Prince ; Lubomir Sokol ; Barbara Balser ; Julie Wolfson ; Bertrand Coiffier | Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial. |
| 002129 (2016) |
Arlene Chan ; Suzette Delaloge ; Frankie A. Holmes ; Beverly Moy ; Hiroji Iwata ; Vernon J. Harvey ; Nicholas J. Robert ; Tajana Silovski ; Erhan Gokmen ; Gunter Von Minckwitz ; Bent Ejlertsen ; Stephen K L. Chia ; Janine Mansi ; Carlos H. Barrios ; Michael Gnant ; Marc Buyse ; Ira Gore ; John Smith ; Graydon Harker ; Norikazu Masuda ; Katarina Petrakova ; Angel Guerrero Zotano ; Nicholas Iannotti ; Gladys Rodriguez ; Pierfrancesco Tassone ; Alvin Wong ; Richard Bryce ; Yining Ye ; Bin Yao ; Miguel Martin | Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. |
| 002545 (2016) |
Patrick Marcellin ; Sang Hoon Ahn ; Xiaoli Ma ; Florin A. Caruntu ; Won Young Tak ; Magdy Elkashab ; Wan-Long Chuang ; Seng-Gee Lim ; Fehmi Tabak ; Rajiv Mehta ; Joerg Petersen ; Graham R. Foster ; Lillian Lou ; Eduardo B. Martins ; Phillip Dinh ; Lanjia Lin ; Amoreena Corsa ; Prista Charuworn ; G Mani Subramanian ; Hans Reiser ; Hendrick W. Reesink ; Scott Fung ; Simone I. Strasser ; Huy Trinh ; Maria Buti ; Giovanni B. Gaeta ; Aric J. Hui ; George Papatheodoridis ; Robert Flisiak ; Henry L Y. Chan | Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B. |
